Welcome to BioMARC

BioMARC serves an industry need for higher containment biologics manufacturing (BSL-2, BSL-3 and Select Agent cGMP manufacturing). BioMARC full time staff of manufacturing experts, best practice methodology and adherence to quality and validation practices along with our extensive network of professionals throughout Colorado State University (CSU) provides the foundation for which our Contract Manufacturing Organization (CMO) operates. Leveraging our numerous strategic partnerships, and investments in facility infrastructure, we can ensure that any project managed by BioMARC, will receive the attention and highest quality deliverables expected from a CMO providing cutting edge solutions.

CSU, as an institution, has been at the forefront of microbial research since its inception over 100 years ago. Past research experience coupled with industry expertise led to the successful establishment of BioMARC in 2006. Through BioMARC, CSU is able to provide these core GMP manufacturing services to select commercial, private, and government entities.

Process & Method Development

Every client's manufacturing process and methods are unique to their product. BioMARC specialized in recreating those specifications during Technology Transfer in a cost effective and efficient way. We also have the expertise to develop or refine new processes and methods necessary to bring a product through each phase of the product development lifecycle.

High Containment Manufacturing

BioMARC specializes in high containment biologics manufacturing. Our facilities and infrastructure provide a clear and easy path from pre-clinical to GMP commercial manufacturing. Our in-house quality system and EHS procedures enable us to plan for a clean, safe and controlled environment. Click here to learn more.

RECENT NEWS & EVENTS

30 May 2017BioMARC Works with CDC to Help Public Health Labs Detect Zika VirusSince the Zika virus was first reported in Florida and Texas, CSU has been researching the virus and working to help improve how states across the country test for viruses carried by mosquitoes. Most recently, CSU’s BioMARC, the university’s vaccine manufacturing facility, created material to be used in labs nationwide in the fight against Zika.....

1 March 2017BioMARC Secures $3 Million from the Department of Defense to Advance Vaccine DevelopmentBioMARC, is using a state-of-the-art system to develop its first drug meant to protect U.S. soldiers from a mosquito-borne pathogen known as Venezuelan equine encephalitis virus that can cause severe illness and death in people......

9 January 2017CSSI LifeSciences™ and BioMARC Announce Strategic Partnership to Provide a Single-Source BioPharmaceutical Manufacturing and Clinical SolutionCSSi LifeSciences™, a trusted partner from discovery to commercialization for biologics and vaccines, announced a strategic partnership with BioMARC. Together, these two organizations offer unparalleled guidance for companies developing either biologics or vaccines.....

04 January 2016CSU's BioMARC Helps Advance Vaccines for Department of DefenseBioMARC has been awarded a 10-month, $4.6 million contract funded by the DoD to help develop and manufacture new vaccines to fight encephalitic viruses....

06 January 2015BioMARC of Colorado State University Awarded Contract to Support HIV Vaccine ProductionBioMARC of Colorado State University (CSU), was recently awarded a new contract to support future manufacturing of an HIV vaccine......

27 October 2014BioMARC of Colorado State University Awarded Ebola SubcontractThe Biopharmaceutical Manufacturing andf Academic Resource Center (BioMARC) at Colorado State University (CSU), has been awarded $2 million by the U.S. Department of Defense (DoD) to aid.....